Found 8 results
Author Title Type [ Year
] Filters: First Letter Of Title is P and Author is Enama, Mary E [Clear All Filters]
. 2015. “Phase 1 Study Of Pandemic H1 Dna Vaccine In Healthy Adults.”. Plos One 10 (4). Plos One: e0123969. doi:10.1371/journal.pone.0123969.
. 2014. “Phase I Randomized Clinical Trial Of Vrc Dna And Rad5 Hiv-1 Vaccine Delivery By Intramuscular (I.m.), Subcutaneous (S.c.) And Intradermal (I.d.) Administration (Vrc 011).”. Plos One 9 (3). Plos One: e91366. doi:10.1371/journal.pone.0091366.
. 2013. “Prime-Boost Interval Matters: A Randomized Phase 1 Study To Identify The Minimum Interval Necessary To Observe The H5 Dna Influenza Vaccine Priming Effect.”. J Infect Dis 208 (3). J Infect Dis: 418-22. doi:10.1093/infdis/jit180.
. 2013. “Protection Against Malaria By Intravenous Immunization With A Nonreplicating Sporozoite Vaccine.”. Science 341 (6152). Science: 1359-65. doi:10.1126/science.1241800.
. 2010. “Priming Immunization With Dna Augments Immunogenicity Of Recombinant Adenoviral Vectors For Both Hiv-1 Specific Antibody And T-Cell Responses.”. Plos One 5 (2). Plos One: e9015. doi:10.1371/journal.pone.0009015.
. 2007. “Phase I Clinical Evaluation Of A Six-Plasmid Multiclade Hiv-1 Dna Candidate Vaccine.”. Vaccine 25 (20). Vaccine: 4085-92. doi:10.1016/j.vaccine.2007.02.050.
. 2006. “Phase 1 Safety And Immunogenicity Evaluation Of A Multiclade Hiv-1 Candidate Vaccine Delivered By A Replication-Defective Recombinant Adenovirus Vector.”. J Infect Dis 194 (12). J Infect Dis: 1638-49. doi:10.1086/509258.
. 2006. “Phase 1 Safety And Immunogenicity Evaluation Of A Multiclade Hiv-1 Dna Candidate Vaccine.”. J Infect Dis 194 (12). J Infect Dis: 1650-60. doi:10.1086/509259.